We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · November 24, 2019

Outcomes in Patients With Diabetes Treated With Biodegradable Sirolimus-Eluting Stents vs Durable Everolimus-Eluting Stents

Journal of the American Heart Association


Additional Info

Journal of the American Heart Association
Five-Year Outcomes in Patients With Diabetes Mellitus Treated With Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents
J Am Heart Assoc 2019 Nov 19;8(22)e013607, JF Iglesias, D Heg, M Roffi, D Tüller, J Lanz, F Rigamonti, O Muller, I Moarof, S Cook, D Weilenmann, C Kaiser, F Cuculi, M Valgimigli, P Jüni, S Windecker, T Pilgrim

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading